Cargando…
Clarithromycin attenuates IL-13–induced periostin production in human lung fibroblasts
BACKGROUND: Periostin is a biomarker indicating the presence of type 2 inflammation and submucosal fibrosis; serum periostin levels have been associated with asthma severity. Macrolides have immunomodulatory effects and are considered a potential therapy for patients with severe asthma. Therefore, w...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319114/ https://www.ncbi.nlm.nih.gov/pubmed/28219384 http://dx.doi.org/10.1186/s12931-017-0519-8 |
_version_ | 1782509320241414144 |
---|---|
author | Komiya, Kosaku Ohta, Shoichiro Arima, Kazuhiko Ogawa, Masahiro Suzuki, Shoichi Mitamura, Yasutaka Nunomura, Satoshi Nanri, Yasuhiro Yoshihara, Tomohito Kawaguchi, Atsushi Kadota, Jun-ichi Rubin, Bruce K. Izuhara, Kenji |
author_facet | Komiya, Kosaku Ohta, Shoichiro Arima, Kazuhiko Ogawa, Masahiro Suzuki, Shoichi Mitamura, Yasutaka Nunomura, Satoshi Nanri, Yasuhiro Yoshihara, Tomohito Kawaguchi, Atsushi Kadota, Jun-ichi Rubin, Bruce K. Izuhara, Kenji |
author_sort | Komiya, Kosaku |
collection | PubMed |
description | BACKGROUND: Periostin is a biomarker indicating the presence of type 2 inflammation and submucosal fibrosis; serum periostin levels have been associated with asthma severity. Macrolides have immunomodulatory effects and are considered a potential therapy for patients with severe asthma. Therefore, we investigated whether macrolides can also modulate pulmonary periostin production. METHODS: Using quantitative PCR and ELISA, we measured periostin production in human lung fibroblasts stimulated by interleukin-13 (IL-13) in the presence of two 14-member–ring macrolides—clarithromycin or erythromycin—or a 16-member–ring macrolide, josamycin. Phosphorylation of signal transducers and activators of transcription 6 (STAT6), downstream of IL-13 signaling, was evaluated by Western blotting. Changes in global gene expression profile induced by IL-13 and/or clarithromycin were assessed by DNA microarray analysis. RESULTS: Clarithromycin and erythromycin, but not josamycin, inhibited IL-13–stimulated periostin production. The inhibitory effects of clarithromycin were stronger than those of erythromycin. Clarithromycin significantly attenuated STAT6 phosphorylation induced by IL-13. Global gene expression analyses demonstrated that IL-13 increased mRNA expression of 454 genes more than 4-fold, while decreasing its expression in 390 of these genes (85.9%), mainly “extracellular,” “plasma membrane,” or “defense response” genes. On the other hand, clarithromycin suppressed 9.8% of the genes in the absence of IL-13. Clarithromycin primarily attenuated the gene expression of extracellular matrix protein, including periostin, especially after IL-13. CONCLUSIONS: Clarithromycin suppressed IL-13–induced periostin production in human lung fibroblasts, in part by inhibiting STAT6 phosphorylation. This suggests a novel mechanism of the immunomodulatory effect of clarithromycin in asthmatic airway inflammation and fibrosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12931-017-0519-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5319114 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53191142017-02-24 Clarithromycin attenuates IL-13–induced periostin production in human lung fibroblasts Komiya, Kosaku Ohta, Shoichiro Arima, Kazuhiko Ogawa, Masahiro Suzuki, Shoichi Mitamura, Yasutaka Nunomura, Satoshi Nanri, Yasuhiro Yoshihara, Tomohito Kawaguchi, Atsushi Kadota, Jun-ichi Rubin, Bruce K. Izuhara, Kenji Respir Res Research BACKGROUND: Periostin is a biomarker indicating the presence of type 2 inflammation and submucosal fibrosis; serum periostin levels have been associated with asthma severity. Macrolides have immunomodulatory effects and are considered a potential therapy for patients with severe asthma. Therefore, we investigated whether macrolides can also modulate pulmonary periostin production. METHODS: Using quantitative PCR and ELISA, we measured periostin production in human lung fibroblasts stimulated by interleukin-13 (IL-13) in the presence of two 14-member–ring macrolides—clarithromycin or erythromycin—or a 16-member–ring macrolide, josamycin. Phosphorylation of signal transducers and activators of transcription 6 (STAT6), downstream of IL-13 signaling, was evaluated by Western blotting. Changes in global gene expression profile induced by IL-13 and/or clarithromycin were assessed by DNA microarray analysis. RESULTS: Clarithromycin and erythromycin, but not josamycin, inhibited IL-13–stimulated periostin production. The inhibitory effects of clarithromycin were stronger than those of erythromycin. Clarithromycin significantly attenuated STAT6 phosphorylation induced by IL-13. Global gene expression analyses demonstrated that IL-13 increased mRNA expression of 454 genes more than 4-fold, while decreasing its expression in 390 of these genes (85.9%), mainly “extracellular,” “plasma membrane,” or “defense response” genes. On the other hand, clarithromycin suppressed 9.8% of the genes in the absence of IL-13. Clarithromycin primarily attenuated the gene expression of extracellular matrix protein, including periostin, especially after IL-13. CONCLUSIONS: Clarithromycin suppressed IL-13–induced periostin production in human lung fibroblasts, in part by inhibiting STAT6 phosphorylation. This suggests a novel mechanism of the immunomodulatory effect of clarithromycin in asthmatic airway inflammation and fibrosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12931-017-0519-8) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-20 2017 /pmc/articles/PMC5319114/ /pubmed/28219384 http://dx.doi.org/10.1186/s12931-017-0519-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Komiya, Kosaku Ohta, Shoichiro Arima, Kazuhiko Ogawa, Masahiro Suzuki, Shoichi Mitamura, Yasutaka Nunomura, Satoshi Nanri, Yasuhiro Yoshihara, Tomohito Kawaguchi, Atsushi Kadota, Jun-ichi Rubin, Bruce K. Izuhara, Kenji Clarithromycin attenuates IL-13–induced periostin production in human lung fibroblasts |
title | Clarithromycin attenuates IL-13–induced periostin production in human lung fibroblasts |
title_full | Clarithromycin attenuates IL-13–induced periostin production in human lung fibroblasts |
title_fullStr | Clarithromycin attenuates IL-13–induced periostin production in human lung fibroblasts |
title_full_unstemmed | Clarithromycin attenuates IL-13–induced periostin production in human lung fibroblasts |
title_short | Clarithromycin attenuates IL-13–induced periostin production in human lung fibroblasts |
title_sort | clarithromycin attenuates il-13–induced periostin production in human lung fibroblasts |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319114/ https://www.ncbi.nlm.nih.gov/pubmed/28219384 http://dx.doi.org/10.1186/s12931-017-0519-8 |
work_keys_str_mv | AT komiyakosaku clarithromycinattenuatesil13inducedperiostinproductioninhumanlungfibroblasts AT ohtashoichiro clarithromycinattenuatesil13inducedperiostinproductioninhumanlungfibroblasts AT arimakazuhiko clarithromycinattenuatesil13inducedperiostinproductioninhumanlungfibroblasts AT ogawamasahiro clarithromycinattenuatesil13inducedperiostinproductioninhumanlungfibroblasts AT suzukishoichi clarithromycinattenuatesil13inducedperiostinproductioninhumanlungfibroblasts AT mitamurayasutaka clarithromycinattenuatesil13inducedperiostinproductioninhumanlungfibroblasts AT nunomurasatoshi clarithromycinattenuatesil13inducedperiostinproductioninhumanlungfibroblasts AT nanriyasuhiro clarithromycinattenuatesil13inducedperiostinproductioninhumanlungfibroblasts AT yoshiharatomohito clarithromycinattenuatesil13inducedperiostinproductioninhumanlungfibroblasts AT kawaguchiatsushi clarithromycinattenuatesil13inducedperiostinproductioninhumanlungfibroblasts AT kadotajunichi clarithromycinattenuatesil13inducedperiostinproductioninhumanlungfibroblasts AT rubinbrucek clarithromycinattenuatesil13inducedperiostinproductioninhumanlungfibroblasts AT izuharakenji clarithromycinattenuatesil13inducedperiostinproductioninhumanlungfibroblasts |